Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stereotype Threat and Self-fulfilling Prophecies

Stereotype Threat and Self-fulfilling Prophecies

When we hold a stereotype about a person, we have expectations that he or she will fulfill that stereotype. A self-fulfilling prophecy is an expectation held by a person that alters his or her behavior in a way that tends to make it true. When we hold stereotypes about a person, we tend to treat the person according to our expectations. This treatment can influence the person to act according to our stereotypic expectations, thus confirming our stereotypic beliefs. Research by Rosenthal and...

Impression Management Techniques IV: Altercasting

Impression Management Techniques IV: Altercasting

Altercasting is a strategic communication technique in which an individual imposes a specific identity or social role onto another person to influence their behavior and shape the interaction. By presuming a role—such as “responsible leader” or “patient person”—altercasting encourages the target to conform to that identity, often aligning their behavior with the expectations associated with the role. The power of this tactic lies in its subtlety; once a role is assigned, it becomes socially...

Schottky Barrier Diode

Schottky Barrier Diode

Schottky barrier diodes are specialized semiconductor devices characterized by their unique construction. This construction involves combining a metal layer with a moderately doped n-type semiconductor material. This combination leads to the formation of a Schottky barrier, a pivotal element that defines the diode's operational characteristics. The core functionality of Schottky barrier diodes is their capacity to allow current to flow in only one direction due to their distinctive...

Introduction to Nuclear Reprogramming

Introduction to Nuclear Reprogramming

Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...

Exon Recombination

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon has three reading...

Reproductive Cloning

Reproductive Cloning

Reproductive cloning is the process of producing a genetically identical copy—a clone—of an entire organism. While clones can be produced by splitting an early embryo—similar to what happens naturally with identical twins—cloning of adult animals is usually done by a process called somatic cell nuclear transfer (SCNT).
Somatic Cell Nuclear Transfer
In SCNT, an egg cell is taken from an animal and its nucleus is removed, creating an enucleated egg. Then a somatic cell—any cell that is not a sex...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Phenotype, Severity, and Therapy of Patients With LRP4 Antibody-Associated Myasthenia Gravis in the German Myasthenia Gravis Registry.

Neurology·2026

Same author

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026

Same author

Neuroglial P2Y<sub>1</sub> receptor signalling differentially contributes to inflammatory neurodegeneration.

Journal of neuroinflammation·2026

Same author

Multicentric prognostic observational study on biomarker profile in immunotherapy-naïve patients with highly active generalized myasthenia gravis (PROGNO-MG): a study protocol.

Neurological research and practice·2026

Same author

Quantitative Assessment of Peripheral Nerve Echogenicity in Children and Adolescents Aged 2-17 Years: A Retrospective Cross-Sectional Ultrasound Study.

Journal of clinical medicine·2026

Same author

Complement Inhibition Therapy in Myasthenic Crisis-A Multicentre Retrospective Analysis of 17 Cases From Germany.

European journal of neurology·2026

Search research articles

Related Experiment Video

Updated: Jun 18, 2026

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

Published on: May 21, 2008

Steve Reed. Interviewed by Charlotte Schubert.

Charlotte Schubert¹

¹Nature Medicine, Washington, DC, USA.

Nature Biotechnology

|November 10, 2009

Summary

The Infectious Disease Research Institute (IDRI) developed an adjuvant to improve flu vaccine effectiveness and supply. This technology is being shared with developing nations to increase access to vital vaccines.

Area of Science:

Biotechnology
Vaccinology
Global Health

Background:

The Infectious Disease Research Institute (IDRI), a not-for-profit biotech company, aims to enhance global access to vaccines for neglected diseases.
IDRI has developed an adjuvant technology to improve the efficacy and production of vaccines.

Discussion:

The organization's adjuvant technology offers a potential solution to increase vaccine effectiveness and supplies, particularly for neglected diseases.
IDRI's strategy involves making its adjuvant technology accessible to vaccine manufacturers in developing nations.
This initiative could significantly impact the availability of essential vaccines in resource-limited settings.

Key Insights:

IDRI's adjuvant technology can boost the effectiveness and supply of vaccines, including those for neglected diseases.

More Related Videos

Enhanced Communication of Tumor Margins Using 3D Scanning and Mapping

Enhanced Communication of Tumor Margins Using 3D Scanning and Mapping

Published on: December 15, 2023

Free-Hand Intracerebroventricular Injections in Mice

Free-Hand Intracerebroventricular Injections in Mice

Published on: January 12, 2024

Related Experiment Videos

Last Updated: Jun 18, 2026

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research

Published on: May 21, 2008

Enhanced Communication of Tumor Margins Using 3D Scanning and Mapping

Enhanced Communication of Tumor Margins Using 3D Scanning and Mapping

Published on: December 15, 2023

Free-Hand Intracerebroventricular Injections in Mice

Free-Hand Intracerebroventricular Injections in Mice

Published on: January 12, 2024

The organization is committed to equitable access by sharing its technology with manufacturers in developing countries.

The H1N1 influenza pandemic highlights the immediate relevance of IDRI's work.

Outlook:

IDRI's model of accessible biotechnology innovation holds promise for addressing global health disparities.
The successful implementation of this technology could lead to wider availability of crucial vaccines worldwide.
Further development and partnerships are anticipated to expand the reach of IDRI's impactful solutions.